Showing results (1191-1200 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 20, 2001
Rationally designed anti-mitotic agents with pro-apoptotic activityF M UckunCurrent Pharmaceutical Design|September 20, 2001
License to kill tumors: how much hope is justified for trail?S Frank, A D EbertCurrent Pharmaceutical Design|July 27, 2001
New issues about melatonin and its effects on the digestive systemV Motilva, J Cabeza, C Alarcón de la LastraCurrent Pharmaceutical Design|July 27, 2001
Antiinflamatory agents less dangerous for gastrointestinal tractM Rodríguez-Téllez, F Argüelles, J M Herrerías, et al.Current Pharmaceutical Design|July 27, 2001
Cytokine therapeutics for asthma: an appraisal of current evidence and future prospectsD Alvarez, R E Wiley, M JordanaCurrent Pharmaceutical Design|July 27, 2001
Specific molecular targets to control tropical diseasesJ B RodriguezCurrent Pharmaceutical Design|July 27, 2001
Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruziR M Lederkremer, L E BertelloCurrent Pharmaceutical Design|July 27, 2001
Modifications in the "upper" velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activitiesJ FahyCurrent Pharmaceutical Design|July 27, 2001
Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockersB T HillCurrent Pharmaceutical Design|July 27, 2001
General and recent aspects of the chemistry and structure-activity relationships of taxoidsF GuérittePageof 1,008